secwatch.observer — SEC 8-K summary
======================================

Issuer:     RESMED INC (RMD)
CIK:        0000943819
Form:       8-K
Filed at:   2023-03-30T23:59:59+00:00
Accession:  0001193125-23-085659
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ResMed Announces Retirement of Chief Administrative Officer and General Counsel David Pendarvis
--------------------------------------------------------------------------------

- David Pendarvis, global general counsel and chief administrative officer, will retire effective June 30, 2023, after over 20 years at ResMed.
- Pendarvis will serve as a consultant from July 1 to December 31, 2023, at a rate of $10,000 per month.
- Amy Wakeham has been appointed Chief Communications and Investor Relations Officer, effective April 1, 2023, and will join the executive leadership team.
- ResMed will conduct an internal search for a successor global general counsel and secretary.
- Pendarvis will remain eligible for a short-term incentive cash payment for fiscal year 2023 based on continued employment through June 30.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/943819/000119312523085659/0001193125-23-085659-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/943819/000119312523085659/d447060d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-085659

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer